Bayer Leads Series B Financing in US Biotech Company
15 Octubre 2020 - 6:55AM
Noticias Dow Jones
By Pietro Lombardi
Bayer AG's impact-investment arm is leading a $17 million series
B financing round in U.S. biotech company Azitra Inc.
Leaps by Bayer is investing $8 million in the clinical-stage
medical dermatology biotech company, it said Thursday.
"The partnership will focus on developing cutting-edge skin
products using engineered and wild-type bacteria for
biotherapeutic, over-the-counter (OTC) and cosmetic applications
leveraging Azitra's technology platform for both live therapeutic
products (LBPs) and consumer programs," it said.
Write to Pietro Lombardi at pietro.lombardi@dowjones.com;
@pietrolombard10
(END) Dow Jones Newswires
October 15, 2020 07:40 ET (11:40 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Bayer (TG:BAYN)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Bayer (TG:BAYN)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
